Removing binding sites for an oncogene can slow cancer cell growth, researchers say
Cancer cell growth could be slowed down by removing binding sites for an oncogene, researchers…
The gene-editing tool CRISPR-Cas9 has taken over the life sciences world since its development in 2012. CRISPR has changed the way biology research is done, simplifying and speeding up the study of diseases and the discovery of drugs, as well as having a huge impact on crop and food development. Among all its possible applications, the fact that CRISPR can be used to tweak the human genome has made it especially promising for previously difficult-to-treat diseases.
But how does CRISPR work? What kind of therapies are being developed? How is the genome-editing market evolving? And how are stakeholders navigating the complex intellectual property around this technology? Find out the answers to these questions and more on this page.
The Genome Editing Toolbox: ZFNS, TALENS, and CRISPR in Biomedicine
This report covers the industry’s most common genome-editing tools, like CRISPR-Cas9, provides exclusive insights by experts, looks at the market, and addresses future applications and challenges of genome-editing tools.
Go to ReportCancer cell growth could be slowed down by removing binding sites for an oncogene, researchers…
Scribe Therapeutics has entered into an agreement with Sanofi which will allow Sanofi use of…
Wageningen University & Research (WUR), and its spinoff Scope Biosciences, have received a grant of…
Sigma-Aldrich Co LLC, along with genOway, a preclinical research model space company, announced today (September…
This week it’s another four interview podcast, and the introduction of a new feature. Our…
Gene therapies for lung cancer can be found by CRISPR genome editing technology, an international…
CRISPR/Cas9 is a commonly used gene editing technique. CRISPR allows the introduction of a desired…
Researchers from Fujita Health University School of Medicine in Japan have been investigating COVID-19 to…
SNIPR Biome has today (August 2) announced that it has been granted a patent for…
The cosmetics industry is looking for greener ingredients as consumers demand more sustainable products. According…
Phytoform, a London- and Boston-based startup, has received a €5M ($5.7M) investment to develop gene-edited…
CRISPR-Cas9 has taken the world by storm with the promise of making gene editing much…